Skip to main content

Table 1 Clinical and epidemiological characteristics of the 35 patients analysed in this study

From: American tegumentary leishmaniasis caused by Leishmania (Viannia) braziliensis: assessment of parasite genetic variability at intra- and inter-patient levels

Patient code Age (years) Sex Clinical form Location of lesion/Code
  Cutaneous Mucosal
1 52 M MCL Arm/1MCL-C Oral / 1MCL-O
2 48 M MCL Nostril/2MCL-C Oral/2MCL-O
3 25 M MCL Arm/3MCL-C Nasal/3MCL-N
4 54 M MCL ND Oral/4MCL-O
5 47 M MCL Arm/5MCL-C Nasal/5MCL-N
Oral/5MCL-O
6 16 M MCL ND Nasal/6MCL-N
7 50 M MCL Face/7MCL-C Nasal/7MCL-N
8 29 M MCL Trunk/8LMC-C Nasal/8MCL-N
9 55 M MCL ND Oral/9MCL-O
10 42 M MCL ND Nasal/10MCL-N
11 52 F MCL Arm/11MCL-C Nasal/11MCL-N
12 25 M MCL Trunk/12MCL-C Oral/12MCL-O
13 52 F MCL ND Oral/13MCL-O
14 54 M MCL Upper lip/14MCL-C Nasal/14MCL-N
15 69 M MCL ND Nasal/15MCL-N
16 65 M MCL ND Oral/16MCL-O
17 63 F ML A Nasal/17ML-N
18 53 M ML A Nasal/18ML-N
19 66 F ML A Nasal/19ML-N
20 71 M ML A Nasal/20ML-N
21 12 M ML A Nasal/21ML-N
22* 49 F ML A Nasal/22ML-N
23* 69 M ML A Nasal/23ML-N
24* 60 M ML A Nasal/24ML-N
25* 77 M ML A Nasal/25ML-N
26* 72 M ML A Nasal/26ML-N
27* 71 F ML A Nasal/27ML-N
28* 39 M ML A Nasal/28ML-N
29* 63 M ML A Nasal/29ML-N
30* 44 F ML A Nasal/30ML-N
31* 31 F ML A Nasal/31ML-N1
Nasal/31ML-N2
32* 29 F ML A Nasal/32ML-N1
Nasal/32ML-N2
33* 72 F ML A Oral/33LM-O
34 49 M DL Arm/ 34DL-C1 Nasal/34DL-N
Trunk/34DL-C2
Leg/34DL-C3
35 41 M DL Nose/35DL-C Nasal/35DL-N
      Oral/35DL-O
  1. *, Patients reporting the absence of an initial cutaneous lesion or scar suggestive of leishmaniasis; M male, F female, MCL, mucocutaneous leishmaniasis, ML mucosal leishmaniasis, DL disseminated leishmaniasis, ND not done, A absence of cutaneous lesion at the time of clinical evaluation.